Related Experiment Video
Updated: Feb 5, 2026

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
Published on: September 10, 2014
Mapping CSC-Mediated Ovarian Cancer Chemoresistance via CXCR4-PET to Guide Precision Cisplatin Re-Sensitization
Lixia Feng1,2,3,4, Simei Zhao1, Zheng Wei5
1Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
Therapy targeting cancer stem cells (CSCs) has been proposed as a promising strategy to reduce chemoresistance and relapse risks in ovarian cancer (OC) patients. However, the lack of targetable markers impedes research progress. Here, we demonstrate that CXC motif chemokine receptor 4 (CXCR4) may be a targetable functional marker of ovarian CSCs and propose a new translational model incorporating targeted imaging and CXCR4 blockade in CXCR4+ tumors. Expression profile analysis of chemoresistant CSC-like ovarian cancer cells highlighted that CXCR4 functions as a potential stemness marker. CXCR4+ ovarian cancer cells exhibited high self-renewal capacity in vitro and in vivo, and an association with chemoresistance. CXCR4 inhibitor AMD3100 significantly impaired the self-renewal ability of CSC-like ovarian cancer cells and enhanced their sensitivity to cisplatin. CXCR4-targeted [68Ga]Ga-Pentixafor was highly specific in delineating CXCR4-high cell line-derived xenografts and patient-derived xenografts (PDXs) via positron emission tomography (PET) imaging, with precise tumor-targeting and persistent retention. A combination of AMD3100 and CDDP exerted an excellent antitumor effect in CXCR4-high PDXs, but not in CXCR4-low PDXs. These results suggest that CXCR4 may represent a functional CSC marker associated with chemoresistance. Moreover, [68Ga]Ga-Pentixafor PET imaging can guide decision-making for AMD3100 therapy, paving the way for further clinical translation.
Insights
Targeting CXC motif chemokine receptor 4 (CXCR4) in ovarian cancer stem cells (CSCs) shows promise. CXCR4 blockade and imaging can improve chemoresistance treatment and reduce relapse risks in ovarian cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Medical Imaging
Background:
- Targeting cancer stem cells (CSCs) is crucial for overcoming chemoresistance and relapse in ovarian cancer (OC).
- Identifying targetable markers for ovarian CSCs remains a significant challenge in OC research.
- CXC motif chemokine receptor 4 (CXCR4) is investigated as a potential functional marker for ovarian CSCs.
Purpose of the Study:
- To evaluate CXCR4 as a targetable marker for ovarian CSCs.
- To develop a translational model for CXCR4-targeted imaging and therapy in OC.
- To assess the efficacy of CXCR4 blockade in combination with chemotherapy.
Main Methods:
- Analysis of CXCR4 expression in chemoresistant ovarian CSC-like cells.
- In vitro and in vivo assessment of self-renewal capacity and chemoresistance.
- Administration of CXCR4 inhibitor AMD3100 and cisplatin (CDDP).
- Positron emission tomography (PET) imaging using CXCR4-targeted [68Ga]Ga-Pentixafor.
Main Results:
- CXCR4 was identified as a potential stemness marker in ovarian CSCs, correlating with self-renewal and chemoresistance.
- AMD3100 impaired CSC self-renewal and enhanced cisplatin sensitivity.
- [68Ga]Ga-Pentixafor PET imaging accurately delineated CXCR4-high tumors in xenografts and patient-derived models.
- Combination therapy of AMD3100 and CDDP showed significant antitumor effects in CXCR4-high tumors but not in CXCR4-low tumors.
Conclusions:
- CXCR4 represents a functional CSC marker associated with chemoresistance in ovarian cancer.
- CXCR4-targeted PET imaging can guide the selection of patients for AMD3100 therapy.
- This approach holds potential for clinical translation in managing ovarian cancer.
More Related Videos
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Uncertainty in Measurement: Accuracy and Precision
Gene Therapy
Ovarian Cycle
Accuracy and Precision

